Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
tags : Car-t symbols : NVS save search
Global CAR-T Therapy Pipeline Analysis Market Report 2023: Increasing Financial Support Provided by Different Organizations to Promote Development and Consumption Drives Growth
Published: 2023-04-06 (Crawled : 22:00) - prnewswire.com
NVSEF | $93.6375 6.88% 82K
|
Health Technology
| Email alert
Add to watchlist
NVS | $92.57 -0.55% 0.0% 910K
|
Health Technology
| Email alert
Add to watchlist
report pipeline global car-t financial therapy growth market
CAR-T Cell Therapy Market Size to Reach USD 9.62 Million in 2030| Emergen Research
Published: 2023-01-09 (Crawled : 16:00) - prnewswire.com
ALPMF | $9.594 43.47% 2.2K
|
Health Technology
|
| O: 3.03%
H: 0.0%
C: 0.0%
NVSEF | $93.6375 6.88% 82K
|
Health Technology
|
| O: 3.12%
H: 0.0%
C: -2.55%
ALPMY | $9.46 -1.11% 500K
|
Manufacturing
|
| O: 0.58%
H: 0.44%
C: -0.31%
NVS | $92.57 -0.55% 0.0% 910K
|
Health Technology
|
| O: 0.76%
H: 0.26%
C: -3.27%
LLY | $745.95 -0.64% -0.1% 1.7M
|
Health Technology
|
| O: 0.29%
H: 0.27%
C: -3.89%
BMY | $48.3 0.96% -0.1% 11M
|
Health Technology
|
| O: 0.16%
H: 0.05%
C: -2.89%
BNTX | $86.19 -0.24% -0.24% 580K
|
Health Technology
|
| O: 1.42%
H: 0.64%
C: -2.27%
research car-t therapy market
FDA approves Novartis Kymriah® CAR-T cell therapy for adult patients with relapsed or refractory follicular lymphoma
Published: 2022-05-27 (Crawled : 23:00) - globenewswire.com
NVS | $92.57 -0.55% 0.0% 910K
|
Health Technology
| Email alert
Add to watchlist
NVSEF | $93.6375 6.88% 82K
|
Health Technology
| Email alert
Add to watchlist
kymriah fda novartis car-t therapy
Novartis receives positive CHMP opinion for Kymriah® CAR-T cell therapy for adult patients with relapsed or refractory follicular lymphoma in Europe
Published: 2022-03-25 (Crawled : 12:20) - globenewswire.com
NVS | $92.57 -0.55% 0.0% 910K
|
Health Technology
|
| O: 1.14%
H: 0.0%
C: 0.0%
kymriah novartis europe car-t positive therapy chmp t-cell
Novartis announces T-Charge™, next-generation CAR-T platform with first-in-human data at ASH 2021
Published: 2021-12-13 (Crawled : 21:00) - globenewswire.com
NVSEF | $93.6375 6.88% 82K
|
Health Technology
|
| O: 0.69%
H: 0.0%
C: 0.0%
NVS | $92.57 -0.55% 0.0% 910K
|
Health Technology
|
| O: 0.17%
H: 0.5%
C: -0.43%
novartis car-t platform charging
New data at ASH spotlight Novartis recently approved Scemblix®, next-generation CAR-T platform and expanding hematology portfolio
Published: 2021-11-04 (Crawled : 15:15) - globenewswire.com
NVSEF | $93.6375 6.88% 82K
|
Health Technology
|
| O: 0.18%
H: 0.0%
C: -0.89%
NVS | $92.57 -0.55% 0.0% 910K
|
Health Technology
|
| O: -0.06%
H: 0.28%
C: 0.18%
INCY | $52.82 0.19% 0.19% 1.8M
|
Health Technology
|
| O: 2.41%
H: 0.0%
C: 0.0%
ema car-t platform
Global CAR-T Therapy Pipeline Report 2021: Market is Expected to Stabilize and Reach $6,100 Million in 2030
Published: 2021-10-29 (Crawled : 12:00) - prnewswire.com
NVS | $92.57 -0.55% 0.0% 910K
|
Health Technology
|
| O: -0.84%
H: 0.18%
C: 0.18%
therapy car-t
Global CAR-T Cell Therapy Markets to 2026: Rising Clinical Trials and Development of New and Effective Therapy Options
Published: 2021-09-28 (Crawled : 16:00) - prnewswire.com
NVSEF | $93.6375 6.88% 82K
|
Health Technology
|
| O: -0.12%
H: 1.77%
C: -0.99%
NVS | $92.57 -0.55% 0.0% 910K
|
Health Technology
|
| O: 0.16%
H: 0.04%
C: -0.51%
JNJ | News | $145.74 0.67% 0.0% 9.3M
|
Health Technology
|
| O: -0.04%
H: 0.5%
C: -0.18%
ABBV | News | $164.66 0.25% -0.15% 4.5M
|
Health Technology
|
| O: -0.09%
H: 0.93%
C: -0.26%
SGMO | $0.4853 -5.95% -6.33% 1.7M
|
Health Technology
|
| O: -1.12%
H: 0.52%
C: -2.17%
AUTL | $4.8 -0.83% -0.83% 1.2M
|
Health Technology
|
| O: -2.67%
H: 1.27%
C: -5.48%
AMGN | $262.77 -0.49% -0.49% 2M
|
Health Technology
|
| O: -0.38%
H: 1.16%
C: -0.01%
clinical trials therapy car-t trials trial t-cell
Alberta sites join network of certified centres to deliver CAR-T therapy, Kymriah (tisagenlecleucel)
Published: 2021-04-28 (Crawled : 14:00) - biospace.com/
NVS | $92.57 -0.55% 0.0% 910K
|
Health Technology
|
| O: -0.37%
H: 0.7%
C: 0.58%
therapy car-t liver
Gainers vs Losers
| 64% | 36% |
Top 10 Gainers
AGBA | News | $1.02 155.0% 57.94% 120M
|
Finance
ZCMD | $2.86 108.76% 52.1% 2.3M
|
Commercial Services
INVO | $1.555 104.6% 51.13% 5M
|
Health Technology
ISPC | $0.437 105.16% 49.53% 37M
|
Professional, Scientific, and T...
WLGS | News | $0.92 84.0% 45.65% 1.6M
|
OST | $0.499 21.38% 45.26% 1.9M
|
XPON | News | $3.1 60.62% 37.74% 17M
|
TIRX | $0.7 44.39% 30.74% 58M
|
BNTC | News | $6.92 44.17% 30.64% 3.5M
|
Health Technology
GGE | $0.035 19.86% 29.3% 64M
|
Your saved searches
Save your searches and get alerts when important news are released.